Candriam Equities L Biotechnology, V2 - Capitalisation

WKN A3DLGT | ISIN LU2026682919 |  Fonds
Factsheet
03.11.26
3.039,67 USD  +0,66 % (+19,94)

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU2314628996 JPMorgan Funds - Thematics - Genetic Therapies I (acc) - EUR +34,45 % +20,44 % 1,47
2 LU1991432631 UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK +36,56 % +23,45 % 1,43
3 LU1725387622 Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 EUR - Accumulating +22,37 % +14,32 % 1,37
4 LU0415392678 Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating +22,19 % +14,32 % 1,36
5 LU0415392249 Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating +21,34 % +14,33 % 1,30
51 LU2026682919 Candriam Equities L Biotechnology, V2 - Capitalisation +25,84 % +23,00 % 1,01
116 CH0113817123 Bellevue Biotech DT CHF +15,56 % +20,51 % 0,63
117 LU1176840327 Protea Fund - Sectoral Biotech Opportunities Fund PF USD +16,14 % +22,02 % 0,61
118 LU3110815787 CPR Invest - Biodiversity - IF1 EURH1 - Acc +8,97 % +11,69 % 0,53
119 LU3110815944 CPR Invest - Biodiversity - IF2 EURH1 - Acc +8,75 % +11,69 % 0,52
120 LU1711916616 Protea Fund - Sectoral Biotech Opportunities Fund IF H CHF +10,91 % +21,96 % 0,37